Latham & Watkins represented Bionomics in the offering. Bionomics Limited, a clinical-stage biopharmaceutical company, has announced the pricing of its initial public offering in the United States...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here